文献速递头颈部肿瘤放疗放疗物理与技术

放疗质量保证能否改善中低收入国家鼻咽癌预后:国际原子能机构前瞻性研究第一阶段报告

Can Radiation Therapy Quality Assurance Improve Nasopharyngeal Cancer Outcomes in Low- and Middle-Income Countries: Reporting the First Phase of a Prospective International Atomic Energy Agency Study.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2021-08-19

本研究为国际原子能机构协调研究项目的第一阶段,前瞻性调查14个中低收入国家中心的放疗资源与鼻咽癌治疗情况,并由专家组进行放疗质量保证审查。134例患者中60.4%存在大体肿瘤体积和高剂量计划靶区勾画和/或剂量学重大方案偏离,仅11.2%计划可接受。研究旨在第二阶段比较质量保证教育后能否减少重大偏离并改善3年无进展生存。

要点

  • 14个中心中13个具备CT模拟机和IMRT能力,5个中心无本地放疗质量保证。
  • 134例患者中60.4%存在GTV和高剂量PTV勾画和/或剂量学重大方案偏离。
  • 仅11.2%计划可接受,28.4%为临界计划,4.2%因肿瘤范围不可避免妥协。

核心结论

  • 中低收入国家鼻咽癌放疗计划不可接受率高是主要问题,需第二阶段验证质量保证教育能否减少偏离并改善预后。

研究设计与样本

  • 国际原子能机构协调研究项目(325-E3-TM-47712)前瞻性两阶段研究,第一阶段调查14个中心放疗资源、患者特征与治疗,并由专家组进行放疗质量保证审查。

主要发现

  • 14个中心中13个(93%)具备CT模拟机和IMRT能力直线加速器,中位直线加速器3台(范围1-13),中位放疗肿瘤医生10名(范围5-51)。
  • 年放疗鼻咽癌病例数中位54例(范围10-627),5/14中心(36%)无本地放疗质量保证。
  • 第一阶段评估134例患者,82.1%有MRI分期,99.3%完成转移灶检查,65.6%为未分化组织学,51%为3期、49%为4期。
  • 放疗质量保证显示81/134例(60.4%)存在大体肿瘤体积和高剂量计划靶区勾画和/或剂量学重大方案偏离,28.4%为临界计划,15例(11.2%)可接受,仅6例(4.2%)因肿瘤范围不可避免妥协。

关键数值与推荐

  • 研究最终目标为比较第一和第二队列,观察质量保证能否减少重大方案偏离并使3年无进展生存改善15%。

临床怎么用

  • 中低收入国家鼻咽癌放疗应重视质量保证,针对GTV和高剂量PTV勾画及剂量学开展审查与教育。

局限性

  • 本报告仅为第一阶段描述性结果,尚未验证质量保证对预后改善的效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Most new nasopharyngeal cancer cases occur in low-income and middle-income countries, and these patients experience poorer overall survival than that of new nasopharyngeal cancer cases in high-income countries. The goal of this research project is to determine whether the introduction of a radiation therapy quality assurance program can ultimately improve outcomes for nasopharyngeal cancer patients in lower-income and middle-income countries. This study reports the results of the first phase of the International Atomic Energy Agency Coordinated Research Project (325-E3-TM-47712). METHODS AND MATERIALS: This prospective study has 2 phases. Phase 1 is a survey of radiation therapy resources, patient characteristics and treatment, and results of radiation therapy quality assurance performed by the expert panel. An educational workshop reviewing phase 1 results for each center was completed before accrual of patients for phase 2. The ultimate aim of the study is to compare the first and second cohort of patients to see if quality assurance can result in fewer major protocol deviations and a 15% improvement in patients' 3-year progression-free survival. RESULTS: Of 14 participating centers, 13 (93%) had computed tomography simulators and linear accelerators (LINAC) with intensity modulated radiation therapy (IMRT) capacity, median 3 LINAC (range, 1-13), and median 10 radiation oncologists (range, 5-51). The annual number of nasopharyngeal cancer cases irradiated was median 54 (range, 10-627). Five of 14 centers (36%) had no local radiation therapy quality assurance. For the current phase 1 study, 134 patients were evaluated, 82.1% had MRI staging, 99.3% had metastatic workup, 65.6% undifferentiated histology, 51% stage 3 and 49% stage 4. Radiation therapy quality assurance revealed 81 (60.4%) of 134 patients had major protocol violations in gross tumor volume and high dose planning target volume contours and/or dosimetry, 28.4% patients had borderline plans, 15 (11.2%) acceptable, and only 6 (4.2%) had inevitable compromise due to tumor extent. CONCLUSIONS: This is the first International Atomic Energy Agency study to address the fundamental issue of treatment quality rather than altered treatment regimens. The high rate of unacceptable radiation therapy plans is a major concern, and we hope phase 2 will show a significant reduction and improved patient outcomes.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Corry J, Ng WT, Moore A, et al. Can Radiation Therapy Quality Assurance Improve Nasopharyngeal Cancer Outcomes in Low- and Middle-Income Countries: Reporting the First Phase of a Prospective International Atomic Energy Agency Study. Int J Radiat Oncol Biol Phys. 2021. PMID: 34418466. doi:10.1016/j.ijrobp.2021.08.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。